For every human disease, there are perhaps multiple pharmacological targets explored in drug development. Furthermore, there are many approaches to drug screening and validation that involve human cell culture and animal models. Human iPSC-derived disease models, 3D tissue models and classical pharmacological testing are all capabilities (services or tools) offered by REPROCELL. The disease focus category pages on the REPROCELL website are an attempt to summarize the key products or services related to these specific diseases. They are areas in which REPROCELL has knowledge and experience through contract research projects or product development.
REPROCELL’s Predictive Drug Discovery Services therapeutic areas include: